Institute of Biophysics and Cell Engineering  
220072 Minsk, Akademicheskaya str. 27

Protective and stimulating compositions for seed treatment









Linked profile in other language
Elena Кniazeva
+375 17 251 5357
Institute of Biophysics and Cell Engineering offers consumers protective and stimulating compositions for seed treatment under a manufacturing agreement and is looking for partners to conclude a distribution services agreement.
Designed for pre-sowing treatment of seeds of grain and industrial crops.

Ingredients: polymers, growth regulators, trace elements and plant protection products.

They cause a starting effect that optimizes the structural and functional state of the seedling and is prolonged at all stages of plant ontogenesis.

They provide an increase in yield up to 4-6 q / ha, an increase in the quality of the crop, a decrease in the chemical load on the environment, and a reduction in the loss of preparations during the processing and transportation of seeds.
Advantages and Innovations
Good compatibility with basic plant protection technologies.
Stage of development
Already on the market
Funding source
State budged
IPR status
Exclusive rights
Secret know-how
Sector group

Organization information

R&D institution
Year established
NACE keywords
A.01.61 - Support activities for crop production
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
Already engaged in transnational cooperation
Additional comments
Directions of fundamental and applied scientific researches of researches of the Institute.

In the field of medical biotechnology:
- genetic engineering - development of innovative biomedical cell products based on genetically modified cells;
- immunology and allergology - development of new methods of treatment and diagnosis of allergic diseases and immune dysfunctions;
- innovative vaccines - development of prototypes of domestic DNA and RNA vaccines for the prevention of viral diseases;
- new approaches to diagnostics - development of new technologies for early diagnosis of diseases and methods of personalized medicine aimed at improving the quality of human life;
- genome editing - somatic, induced pluripotent stem cells, which will allow to treat diseases, including orphan, genetic ones;
- synthetic morphogenesis - including engineering of tissues and organs.

In the field of bioinformatics technologies:
- structurally based design of new generation drugs, development of innovative targeted anticancer and antiviral drugs using structural bioinformatics methods;
- synthesis of targeted drugs and their testing under in vitro conditions.

In the field of nanotheranostics and personalized nanomedicine:
- development of means of targeted delivery of therapeutic drugs of a new generation using nanomaterials;
- development of biological nanochips for the diagnosis of diseases;
- study of biocompatible nanomaterials with a wide spectrum of action for the creation of biomedical cellular products, artificial organs, fundamentally new materials with antimicrobial, antiviral and anti-inflammatory activity.

Activities of the Center for Experimental and Applied Virology:
- cultivation of viruses, development of new methods of cultivation of human viruses to create diagnostic tools, medical prevention and treatment of viral diseases;
- creation of prototype vaccines - against influenza (inactivated and recombinant), against African swine fever (vector), against pulmonary tuberculosis (therapeutic based on donor dendritic cells), innovative drugs against influenza.

Over the past years, the Institute has been fulfilling a number of international contracts and agreements within the Framework Programs of the European Union, as well as with leading scientific centers, foundations, and societies.
Languages spoken

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing protective and stimulating seed treatment formulations under a manufacturing agreement.

Partners interested in purchasing protective and stimulating compounds for seed treatment under a distribution services agreement.
Type and size of partner sought
> 500 MNE
> 500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
Sole proprietor
Views: 495
Statistics since 01.07.2023 20:50:46